These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33393677)

  • 1. Proton pump inhibitors and risk of all-cause and cause-specific mortality: A cohort study.
    Brown JP; Tazare JR; Williamson E; Mansfield KE; Evans SJ; Tomlinson LA; Bhaskaran K; Smeeth L; Wing K; Douglas IJ
    Br J Clin Pharmacol; 2021 Aug; 87(8):3150-3161. PubMed ID: 33393677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance Proton Pump Inhibitor Use Associated with Increased All-Cause and Cause-Specific Mortality in Sweden.
    Ngwenya S; Simin J; Brusselaers N
    Dig Dis Sci; 2023 Jun; 68(6):2252-2263. PubMed ID: 36629968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
    Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID-19: Evidence from a large population-based cohort study.
    Zeng R; Ma Y; Zhang L; Luo D; Jiang R; Wu H; Zhuo Z; Yang Q; Li J; Leung FW; Duan C; Sha W; Chen H
    Elife; 2024 Jul; 13():. PubMed ID: 39012339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
    Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
    Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.
    Bajaj JS; Ratliff SM; Heuman DM; Lapane KL
    Aliment Pharmacol Ther; 2012 Nov; 36(9):866-74. PubMed ID: 22966967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between proton pump inhibitors use and risk of hip fracture: A general population-based cohort study.
    Wei J; Chan AT; Zeng C; Bai X; Lu N; Lei G; Zhang Y
    Bone; 2020 Oct; 139():115502. PubMed ID: 32593677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton-Pump Inhibitors and Risk of Calcium Pyrophosphate Deposition in a Population-Based Study.
    Liew JW; Peloquin C; Tedeschi SK; Felson DT; Zhang Y; Choi HK; Terkeltaub R; Neogi T
    Arthritis Care Res (Hoboken); 2022 Dec; 74(12):2059-2065. PubMed ID: 35245410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Concomitant Metformin and Proton Pump Inhibitor Use: A Population Retrospective Cohort Study.
    Chen CB; Lin M; Eurich DT; Johnson JA
    Clin Ther; 2016 Jun; 38(6):1392-1400. PubMed ID: 27061884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between acid-suppressive drug use and atopic dermatitis in patients with upper gastrointestinal diseases: A population-based retrospective cohort study.
    Lin HC; Chen YY; Lin HL; Uang YS; Ho Y; Wang LH
    J Clin Pharm Ther; 2021 Jun; 46(3):786-793. PubMed ID: 33403692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of proton pump inhibitors versus histamine-2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers.
    Fan HP; Zhou Y; Chen ML; Qiu KH; Feng X; Zhou C; Zhu ML; Huang RZ; Hu TY
    Pharmacotherapy; 2024 Jul; 44(7):539-548. PubMed ID: 38899757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study.
    Park J; You SC; Cho J; Park CH; Shin WG; Park RW; In Seo S
    BMC Pharmacol Toxicol; 2022 Jan; 23(1):9. PubMed ID: 35039078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal and Infant Exposure to Acid-Suppressive Medications and Risk of Allergic Diseases in Children.
    Noh Y; Jeong HE; Choi A; Choi EY; Pasternak B; Nordeng H; Bliddal M; Man KKC; Wong ICK; Yon DK; Shin JY
    JAMA Pediatr; 2023 Mar; 177(3):267-277. PubMed ID: 36622684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
    Landi SN; Sandler RS; Pate V; Lund JL
    Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors and risk of gastric cancer: population-based cohort study.
    Abrahami D; McDonald EG; Schnitzer ME; Barkun AN; Suissa S; Azoulay L
    Gut; 2022 Jan; 71(1):16-24. PubMed ID: 34226290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
    Wu CL; Lei WY; Wang JS; Lin CE; Chen CL; Wen SH
    PLoS One; 2020; 15(11):e0242975. PubMed ID: 33253311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors and risk of colorectal cancer.
    Abrahami D; McDonald EG; Schnitzer ME; Barkun AN; Suissa S; Azoulay L
    Gut; 2022 Jan; 71(1):111-118. PubMed ID: 34210775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.